Redbiotec is one of the partners who were granted the Edufluvac project in the frame of the EU FP7-HEALTH.2013.2.3.0-1 package (EU contribution €4.6M). The project aims towards “universal” influenza vaccines, providing longer-lasting and broader protection against multiple strains of the virus, ultimately protecting
the general population from seasonal and pandemic influenza. [Press release]
